Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells

Journal of Neurochemistry

Volumn 105, Issue 5, 2008, Pages 1596-1612

  Xifró, Xavier ^c   García Martínez, Juan Manuel ^b,c   Del Toro, Daniel ^c   Alberch, Jordi ^c   Pérez Navarro, Esther ^a,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Calpain; Caspase; Death associated protein kinase; Excitotoxicity; FK 506; Huntington's disease

Indexed keywords

CALCINEURIN; CALPAIN; HUNTINGTIN; N METHYL DEXTRO ASPARTIC ACID; TACROLIMUS;

ANIMAL CELL; ARTICLE; CELL DEATH; ENZYME ACTIVATION; EXCITOTOXICITY; HUNTINGTON CHOREA; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; CALCINEURIN; CELL DEATH; CELL LINE, TRANSFORMED; CELL SURVIVAL; CELLS, CULTURED; CORPUS STRIATUM; HUNTINGTON DISEASE; MICE; MICE, INBRED C57BL; MUTATION; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS;

EID: 43549092044     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05252.x     Document Type: Article

References (67)

1. Almeida S., Domingues A., Rodrigues L., Oliveira C. R. Rego C. (2004) FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol. Dis. 17, 435 444.
2. Ankarcrona M., Dypbukt J. M., Orrenius S. Nicotera P. (1996) Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 394, 321 324.
3. Asai A., Qiu J., Narita Y., Chi S., Saito N., Shinoura N., Hamada H., Kuchino Y. Kirino T. (1999) High level calcineurin activity predisposes neuronal cells to apoptosis. J. Biol. Chem. 274, 34450 34458.
4. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J. Martin J. B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168 171.
5. Beal M. F., Ferrante R. J., Swartz K. J. Kowall N. W. (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11, 1649 1659.
6. Beal M. F., Brouillet E., Jenkins B. J. et al. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181 4192.
7. Beals C. R., Clipstone N. A., Ho S. N. Crabtree G. R. (1997) Nuclear localization of NF-Atc by a calcineurin-dependent, cyclosporine-sensitive intramolecular interaction. Genes Dev. 11, 824 834.
8. Bezprozvanny I. Hayden M. R. (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem. Biophys. Res. Commun. 322, 1310 1317.
9. Bialik S. Kimchi A. (2006) The death-associated protein kinase: structure, function and beyond. Annu. Rev. Biochem. 75, 189 210.
10. Bizat N., Hermel J. M., Boyer F. et al. (2003) Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J. Neurosci. 23, 5020 5030.
11. Bizat N., Galas M. C., Jacquard C., Boyer F., Hermel J. M., Schiffmann S. N., Hantraye P., Blum D. Brouillet E. (2005) Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. Neuropharmacology 49, 695 702.
12. Brorson J. R., Marcuccilli C. J. Miller R. J. (1995) Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26, 1259 1266.
13. Brouillet E., Guyot M. C., Mittoux V., Altairac S., Conde F., Palfi S. Hantraye P. (1998) Partial inhibition of brain succinate dehidrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J. Neurochem. 70, 794 805.
14. Butcher S. P., Henshall D. C., Teramura Y., Iwasaki K. Sharkey J. (1997) Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17, 6939 6946.
15. Choe E. S., Shin E. H. Wang J. Q. (2005) Inhibition of protein phosphatase 2B upregulates serine phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in striatal neurons in vivo. Neurosci. Lett. 384, 38 43.
16. Choo Y. S., Johnson G. V. W., MacDonald M., Detloff P. J. Lesort M. (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13, 1407 1420.
17. Clipstone N. A., Fiorentino D. F. Crabtree G. R. (1994) Molecular analysis of calcineurin with drug-immunophilin complexes. J. Biol. Chem. 269, 26431 26437.
18. Dawson T. M., Steiner J. P., Dawson V. L., Dinerman J. L., Uhl G. R. Snyder S. H. (1993) Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl Acad. Sci. USA 90, 9808 9812.
19. DiFiglia M. (1990) Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 13, 286 289.
20. Fan M. M. Raymond L. A. (2007) N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol. 81, 272 293.
21. Ferrand-Drake M., Zhu C., Gidö G. et al. (2003) Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis-inducing factor, cytochrome c and caspase-3 activation in neurons exposed to transient hypoglycemia. J. Neurochem. 85, 1431 1442.
22. Gafni J., Hermel E., Young J. E., Wellington C. L., Hayden M. R. Ellerby L. M. (2004) Inhibition of calpain cleavage of huntingtin reduces toxicity. J. Biol. Chem. 279, 20211 20220.
23. Gauthier L. R., Charrin B. C., Borrell-Pages M. et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127 138.
24. Gines S., Ivanova E., Seong I. S., Saura C. A. MacDonald M. E. (2003) Enhanced Akt signalling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. J. Biol. Chem. 278, 50514 50522.
25. Giordano M., Takashima H., Herranz A., Pottorak M., Geller H. M., Marone M. Freed W. J. (1993) Immortalized GABAergic cell lines derived from rat striatum using a temperature-sensitive allele of the SV 40 large T antigen. Exp. Neurol. 124, 395 400.
26. Goll D. E., Thompson V. F., Li H., Wei W. Cong J. (2003) The calpain system. Physiol. Rev. 83, 731 801.
27. Goto S., Matsukado Y., Miyamoto E. Yamada M. (1987) Morphological characterization of the rat striatal neurons expressing calcineurin immunoreactivity. Neuroscience 22, 189 201.
28. Gratacos E., Checa N., Perez-Navarro E. Alberch J. (2001) Brain-derived neurotrophic factor (BDNF) mediated bone-morphogenetic protein-2 (BMP-2) effects on cultured striatal neurons. J. Neurochem. 79, 747 755.
29. Hansson O., Petersen A., Leist M., Nicotera P., Castilho R. F. Brundin P. (1999) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl Acad. Sci. USA 96, 8727 8732.
30. Hengartner M. O. (2000) The biochemistry of apoptosis. Nature 407, 770 776.
31. Hernandez-Espinosa D. Morton A. J. (2006) Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation. Brain Res. Bull. 69, 669 679.
32. Jang C. W., Chen C. H., Chen C. C., Chen J. Y., Su Y. H. Chen R. H. (2002) TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat. Cell Biol. 4, 51 58.
33. Johnson P. (1990) Calpains (intracellular calcium-activated cysteine proteinases): structure-activity relationships and involvement in normal and abnormal cellular metabolism. Int. J. Biochem. 22, 811 822.
34. Lievens J. C., Woodman B., Mahal A. Bates G. P. (2002) Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntington's disease transgenic mice. Mol. Cell. Neurosci. 20, 638 648.
35. Luo S., Vacher C., Davies J. E. Rubinzstein D. C. (2005) Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J. Cell Biol. 169, 647 656.
36. Luthi-Carter R., Strand A., Peters N. L. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9, 1259 1271.
37. Metzler M., Gan L., Wong T. P. et al. (2007) NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1. J. Neurosci. 27, 2298 2308.
38. Milakovic T., Quintanilla R. A. Johnson G. V. W. (2006) Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells. J. Biol. Chem. 281, 34785 34795.
39. Mukerjee N., McGinnis K. M., Park Y. H., Gnegy M. E. Wang K. K. (2000) Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. Arc. Biochem. Biophys. 379, 337 343.
40. Nicholls D. G. Ward M. W. (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23, 166 174.
41. Nishi A., Bibb J. A., Matsuyama S., Hamada M., Higashi H., Nairn A. C. Greengard P. (2002) Regulation of DARPP-32 dephosphorylation at PKA- and cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A. J. Neurochem. 81, 832 841.
42. Oliveira J. M. A., Chen S., Almeida S. et al. (2006) Mitochondrial- dependent calcium handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors. J. Neurosci. 26, 11174 11186.
43. Pardo R., Colin E., Regulier E., Aebischer P., Deglon N., Humbert S. Saudou F. (2006) Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421. J. Neurosci. 26, 1635 1645.
44. Perez-Navarro E., Gavalda N., Gratacos E. Alberch J. (2005) Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum. J. Neurochem. 92, 678 691.
45. Perez-Navarro E., Canals J. M., Gines S. Alberch J. (2006) Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease. Histol. Histopathol. 21, 1217 1232.
46. Rangone H., Poizat G., Troncoso J., Ross C. A., MacDonald M. E., Saudou F. Humbert S. (2004) The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylation serine 421 of huntingtin. Eur. J. Neurosci. 19, 273 279.
47. Rangone H., Pardo R., Colin E., Girault J. A., Saudou F. Humbert S. (2005) Phosphorylation of arfaptin 2 at Ser260 by Akt inhibits PolyQ-Huntingtin-induced toxicity by rescuing proteasome impairment. J. Biol. Chem. 280, 22021 22028.
48. Rusnak F. Mertz P. (2000) Calcineurin: form and function. Physiol. Rev. 80, 1483 1521.
49. Saeki M., Irie Y., Ni L., Itsuki Y., Terao Y., Kawabata S. Kamisaki Y. (2007) Calcineurin potentiates the activation of procaspase-3 by accelerating its proteolytic maturation. J. Biol. Chem. 282, 11786 11794.
50. Seong I. S., Ivanova E., Lee J. M. et al. (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum. Mol. Genet. 14, 2871 2880.
51. Shamloo M., Soriano L., Wieloch T., Nikolich K., Urfer R. Oksenberg D. (2005) Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia. J. Biol. Chem. 280, 42290 42299.
52. Shehadeh J., Fernandez H. B., Zeron Mullis M. M., Graham R. K., Leavitt B. R., Hayden M. R. Raymond L. A. (2006) Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington's disease. Neurobiol. Dis. 21, 392 403.
53. Shibasaki F. McKeon F. (1995) Calcineurin functions in calcium-activated cell death in mammalian cells. J. Cell Biol. 131, 735 743.
54. Shioda N., Moriguchi S., Shirasaki Y. Fukunaga K. (2006) Generation of constitutively active calcineurin by calpain contributes to delayed neuronal death following mouse brain ischemia. J. Neurochem. 98, 310 320.
55. Springer J. E., Azbill R. D., Nottingham S. A. Kennedy S. E. (2000) Calcineurin-mediated bad dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J. Neurosci. 20, 7246 7251.
56. Tenneti L. Lipton S. A. (2000) Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J. Neurochem. 74, 134 142.
57. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971 983.
58. Torres-Peraza J. F., Giralt A., Garcia-Martínez J. M., Pedrosa E., Canals J. M. Alberch J. (2007) Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodelling of both postsynaptic density and NMDA receptor signalling. Neurobiol. Dis. (In press).
59. Trettel F., Rigamonti D., Hilditch-Maguire P., Wheeler V. C., Sharp A. H., Persichetti F., Cattaneo E. MacDonald M. E. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9, 2799 2809.
60. Wang H. G., Pathan N., Ethell I. M. et al. (1999) calcium-induced apoptosis through calcineurin dephosphorylation of bad. Science 284, 339 343.
61. Wood A. M. Bristow D. R. (1998) N-methyl-D-aspartate receptor desensitisation is neuroprotective by inhibiting glutamate-induced apoptotic-like death. J. Neurochem. 70, 677 687.
62. Wu H. Y., Tomizawa K., Oda Y., Wei F. Y., Lu Y. F., Matsushita M., Li S. T., Moriwaki A. Matsui H. (2004) Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J. Biol. Chem. 279, 4929 4940.
63. Wüllner U., Young A. B., Penney J. B. Beal M. F. (1994) 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63, 1772 1781.
64. Xifro X., Malagelada C., Minano A. Rodriguez-Alvarez J. (2005) Brief exposure to NMDA produces long-term protection of cerebellar granule cells from apoptosis. Eur. J. Neurosci. 21, 827 840.
65. Yang L., Omori K., Suzukawa J. Inagaki C. (2004) Calcineurin-mediated bad ser155 dephosphorylation in ammonia-induced apoptosis in cultured rat hippocampal neurons. Neurosci. Lett. 357, 73 75.
66. Zeron M. M., Hansson O., Chen N., Wellington C. L., Leavitt B. R., Brundin P., Hayden M. R. Raymond L. A. (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33, 849 860.
67. Zeron M. M., Fernandes H. B., Krebs C., Shehadeh J., Wellington C. L., Leavitt B. R., Baimbridge K. G., Hayden M. R. Raymond L. A. (2004) Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease. Mol. Cell. Neurosci. 25, 469 479.